Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Porfimer sodium photodynamic therapy plus stenting versus stenting alone in advanced biliary tract tumours
2005-001173-96Phase 3Completed
- Sponsor
- University College London
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of porfimer sodium in cholangiocarcinoma (CCA) and biliary cancer (2 arms), sponsored by University College London. Primary endpoint: Overall survival. Started Sep 2005; status: completed.
02
Drugs
porfimer sodium
03
Conditions
cholangiocarcinoma (CCA)biliary cancer
Beyond the preview
Go deeper on 2005-001173-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001173-96.